Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Dubeau

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Nature Communications|May 25, 2016
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolutionThomas E Bartlett, Kantaraja Chindera, Jacqueline McDermott, et al.
Oncogene|May 1, 2021
Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesisDaisy Flores Rangel, Louis Dubeau, Ryan Park, et al.
Cancer Research|January 18, 2008
Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor developmentDezheng Dong, Min Ni, Jianze Li, et al.
Clinical Epigenetics|July 22, 2018
Self-reported prenatal tobacco smoke exposure, AXL gene-body methylation, and childhood asthma phenotypesLu Gao, Xiaochen Liu, Joshua Millstein, et al.
Plos One|October 22, 2015
Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived ScentYing Liu, Malcolm C Pike, Nancy Wu, et al.
Cell Metabolism|June 23, 2026
Methionine-supplemented longevity diet increases growth hormone, GLP-1, and FGF21; reduces frailty; and promotes healthspanMaura Fanti, Sebastian Brandhorst, Gerardo Navarrete, et al.
Ebiomedicine|December 3, 2015
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation CarriersMartin Widschwendter, Matthew Burnell, Lindsay Fraser, et al.
The Lancet. Oncology|October 22, 2013
The sex hormone system in carriers of BRCA1/2 mutations: a case-control studyMartin Widschwendter, Adam N Rosenthal, Sue Philpott, et al.
International Journal of Cancer|July 22, 2009
HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle studyMartin Widschwendter, Sophia Apostolidou, Allison A Jones, et al.
International Journal of Cancer|January 29, 2026
The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancerElisa Redl, Chiara Herzog, Charlotte Vavourakis, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Nature Communications|May 25, 2016
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolutionThomas E Bartlett, Kantaraja Chindera, Jacqueline McDermott, et al.
Oncogene|May 1, 2021
Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesisDaisy Flores Rangel, Louis Dubeau, Ryan Park, et al.
Cancer Research|January 18, 2008
Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor developmentDezheng Dong, Min Ni, Jianze Li, et al.
Clinical Epigenetics|July 22, 2018
Self-reported prenatal tobacco smoke exposure, AXL gene-body methylation, and childhood asthma phenotypesLu Gao, Xiaochen Liu, Joshua Millstein, et al.
Plos One|October 22, 2015
Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived ScentYing Liu, Malcolm C Pike, Nancy Wu, et al.
Cell Metabolism|June 23, 2026
Methionine-supplemented longevity diet increases growth hormone, GLP-1, and FGF21; reduces frailty; and promotes healthspanMaura Fanti, Sebastian Brandhorst, Gerardo Navarrete, et al.
Ebiomedicine|December 3, 2015
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation CarriersMartin Widschwendter, Matthew Burnell, Lindsay Fraser, et al.
The Lancet. Oncology|October 22, 2013
The sex hormone system in carriers of BRCA1/2 mutations: a case-control studyMartin Widschwendter, Adam N Rosenthal, Sue Philpott, et al.
International Journal of Cancer|July 22, 2009
HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle studyMartin Widschwendter, Sophia Apostolidou, Allison A Jones, et al.
International Journal of Cancer|January 29, 2026
The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancerElisa Redl, Chiara Herzog, Charlotte Vavourakis, et al.
Pageof 7